Healthcare · NSE/BSE: NH
Narayana Hrudayalaya Ltd.
Hospital
Market Cap ₹0.38L Cr
Verdict: High
Quality Scores
Multi-Bagger
82/100
Compounder Quality
89/100
Management Credibility
92/100
Governance
94/100
Cash Flow Quality
95/100
AI Summary
Narayana Hrudayalaya (NH) has transformed from a domestic cardiac-focused chain into a diversified multi-specialty healthcare powerhouse with a significant international profit engine in the Cayman Islands. Over the last decade, sales have grown at a 17% CAGR, while net profit has accelerated significantly in the post-pandemic era due to operating leverage and a richer case mix. The company's unique value proposition of high-volume, low-cost efficient healthcare is now being augmented by premiumization and digital transformation. Financial performance in the last 4 years is particularly…
Top Opportunities
- Consistent 10-year revenue CAGR of 17%
- Exceptional PAT growth post-pandemic
- Zero equity dilution over the last decade
Top Risks
- Significant debt spike projected for Mar 2026
- DII holding has seen a steady decline
- Capex intensity is increasing sharply
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.